4.59

1.50% -0.07

After Hours: 4.59

Bolt Biotherapeutics Inc (BOLT)

Overview News Price History Financials Discussions Forecast

Bolt Biotherapeutics Inc stock is traded at $4.59, with a volume of 16,333. It is down -1.50% in the last 24 hours and down -6.90% over the past month. Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company is focused on the clinical development of BDC-4182, its claudin 18.2 ISAC. Its other pipeline programs include CEA ISAC program a Boltbody ISAC targeting carcinoembryonic antigen cell adhesion molecule 5, or CEA; PD-L1 ISAC utilizes a novel human anti-PD-L1 antibody conjugated to a next-generation TLR7/8 agonist payload via a non-cleavable linker; and BDC-3042, its dectin-2 agonist antibody program, developed to repolarize critical cells in the tumor microenvironment known as tumor associated macrophages. It operates in single segment.

Previous Close:

$4.66

Open:

$4.67

24h Volume:

16,333

Relative Volume:

0.63

Market Cap:

$8.82M

Revenue:

$7.70M

Net Income/Loss:

$-33.38M

P/E Ratio:

-0.3728

EPS:

-12.3134

Net Cash Flow:

$-39.92M

1W Performance:

-3.57%

1M Performance:

-6.90%

6M Performance:

-3.97%

1Y Performance:

-34.05%

1-Day Range:

$4.58

$4.775

1-Week Range:

$4.56

$5.19

52-Week Range:

$3.91

$9.248

Bolt Biotherapeutics Inc Stock (BOLT) Company Profile

Name

Bolt Biotherapeutics Inc

Sector

Healthcare (1111)

Industry

Biotechnology (621)

Phone

650-665-9295

Address

900 CHESAPEAKE DRIVE, REDWOOD CITY

Employee

Twitter

Next Earnings Date

2026-05-11

Latest SEC Filings

BOLT's Discussions on Twitter

Compare BOLT vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BOLT Bolt Biotherapeutics Inc	4.59	8.95M	7.70M	-33.38M	-39.92M	-12.31
VRTX Vertex Pharmaceuticals Inc	427.65	107.87B	12.32B	4.34B	3.19B	16.86
REGN Regeneron Pharmaceuticals Inc	721.05	73.63B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	807.55	49.42B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	303.00	40.20B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	313.32	33.06B	5.36B	287.73M	924.18M	2.5229

Bolt Biotherapeutics Inc Stock (BOLT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-20-25	Resumed	H.C. Wainwright	Buy
Jan-06-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Mar-02-21	Initiated	Guggenheim	Buy
Mar-02-21	Initiated	Morgan Stanley	Overweight
Mar-02-21	Initiated	SVB Leerink	Outperform
Mar-02-21	Initiated	Stifel	Buy

View All

Bolt Biotherapeutics Inc Stock (BOLT) Latest News

Apr 28, 2026

Bolt Biotherapeutics (BOLT) 2026 proxy details director votes and auditor - Stock Titan

Apr 28, 2026

Apr 20, 2026

Is Bolt Bio (BOLT) stock moving unpredictably (Trend Strengthens) 2026-04-20Community Pattern Alerts - Cổng thông tin điện tử Tỉnh Sơn La

Apr 20, 2026

Apr 17, 2026

Operating cash flow per share of Bolt Biotherapeutics, Inc. – MUN:6LP0 - TradingView

Apr 17, 2026

Apr 13, 2026

Aug Movers: Is Bolt Biotherapeutics Inc still a buy after recent gainsMarket Activity Summary & Verified Momentum Stock Ideas - baoquankhu1.vn

Apr 13, 2026

Apr 10, 2026

Treasury Yields: Will Bolt Biotherapeutics Inc announce a stock splitWeekly Loss Report & Daily Volume Surge Trade Alerts - baoquankhu1.vn

Apr 10, 2026

What is the price target for Bolt Bio (BOLT) Stock | Price at $4.75, Up 5.21%Trade Entry - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 10, 2026

Apr 08, 2026

BOLT STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Bolt Biotherapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 08, 2026

Is momentum building in Bolt Bio (BOLT) Stock | Price at $4.81, Up 0.63%New Listings - Newser

Apr 08, 2026

Apr 07, 2026

Performance Recap: Is Bolt Biotherapeutics Inc still a buy after recent gains2026 Buyback Activity & Stepwise Swing Trade Plans - baoquankhu1.vn

Apr 07, 2026

Apr 06, 2026

Is Bolt Bio (BOLT) Stock Ready to Drop | Price at $4.56, Up 6.29%Certified Trade Ideas - Newser

Apr 06, 2026

Mar 31, 2026

Technical Analysis: Will Bolt Biotherapeutics Inc announce a stock splitTrade Exit Report & Community Consensus Stock Picks - baoquankhu1.vn

Mar 31, 2026

Sentiment Watch: Is Bolt Biotherapeutics Inc on track to beat earnings2026 Outlook & Precise Swing Trade Entry Alerts - baoquankhu1.vn

Mar 31, 2026

Mar 30, 2026

Income Plays: Is Bolt Biotherapeutics Inc impacted by rising ratesEarnings Summary Report & Weekly Setup with High ROI Potential - baoquankhu1.vn

Mar 30, 2026

Entry Recap: Is Bolt Biotherapeutics Inc undervalued by DCF analysisInsider Selling & High Conviction Investment Ideas - baoquankhu1.vn

Mar 30, 2026

Institution Moves: What is the long term forecast for Bolt Biotherapeutics Inc stock2026 Price Action Summary & Growth Focused Entry Reports - baoquankhu1.vn

Mar 30, 2026

Fund Flows: Is Bolt Biotherapeutics Inc still a buy after recent gains2026 Breakouts & Weekly Return Optimization Alerts - baoquankhu1.vn

Mar 30, 2026

Mar 29, 2026

Aug Sectors: What are Bolt Biotherapeutics Incs earnings expectationsTrade Entry Report & AI Powered Market Entry Ideas - baoquankhu1.vn

Mar 29, 2026

Mar 27, 2026

Momentum Shift: Is Bolt Biotherapeutics Inc still a buy after recent gains2026 Institutional & Stepwise Trade Signal Guides - baoquankhu1.vn

Mar 27, 2026

Mar 26, 2026

Trend Recap: Will Bolt Biotherapeutics Inc outperform its industry peersWeekly Trade Analysis & Long Hold Capital Preservation Tips - baoquankhu1.vn

Mar 26, 2026

Bolt Biotherapeutics discloses new STING agonist immunoconjugates - BioWorld News

Mar 26, 2026

Mar 25, 2026

Bronstein, Gewirtz and Grossman, LLC sends a Class Action Lawsuit reminder to shareholder investors for Bolt Biotherapeutics, Inc. to Lead the Class Action Lawsuit! - ACCESS Newswire

Mar 25, 2026

CEO Change: Is Bolt Biotherapeutics Inc on track to beat earnings2026 Chart Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn

Mar 25, 2026

Bolt Biotherapeutics (BOLT) to Release Quarterly Earnings on Wednesday - Defense World

Mar 25, 2026

Mar 22, 2026

If You Invested $1,000 in Bolt Biotherapeutics, Inc. (BOLT) - Stock Titan

Mar 22, 2026

Buyout Rumor: Is Bolt Biotherapeutics Inc undervalued by DCF analysisInsider Buying & Technical Pattern Based Signals - baoquankhu1.vn

Mar 22, 2026

Market Outlook: Is Bolt Biotherapeutics Inc likely to announce a buybackEarnings Miss & Short-Term Swing Trade Alerts - baoquankhu1.vn

Mar 22, 2026

Mar 21, 2026

Market Leaders: Is Bolt Biotherapeutics Inc likely to announce a buyback2026 Action & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn

Mar 21, 2026

Sell Signal: Will Bolt Biotherapeutics Inc outperform its industry peersPortfolio Gains Summary & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn

Mar 21, 2026

Mar 20, 2026

What is the long term forecast for Bolt Biotherapeutics Inc stock2026 News Drivers & Fast Gain Stock Tips - baoquankhu1.vn

Mar 20, 2026

Mar 18, 2026

Weekly Earnings: Is Bolt Biotherapeutics Inc stock a smart retirement pick2026 Bull vs Bear & Free Accurate Trade Setup Notifications - baoquankhu1.vn

Mar 18, 2026

Mar 17, 2026

Fundamentals Check: Does Bolt Biotherapeutics Inc have strong EBITDA margins2026 Bull vs Bear & Community Consensus Trade Signals - baoquankhu1.vn

Mar 17, 2026

Mar 14, 2026

Whats the outlook for Bolt Biotherapeutics Incs sector2026 Analyst Calls & Long Hold Capital Preservation Plans - baoquankhu1.vn

Mar 14, 2026

Mar 13, 2026

Market Outlook: Is Bolt Biotherapeutics Inc stock a smart retirement pick2026 Weekly Recap & High Conviction Trade Alerts - baoquankhu1.vn

Mar 13, 2026

HC Wainwright Reiterates Buy Rating for Bolt Biotherapeutics (BO - GuruFocus

Mar 13, 2026

Bolt Biotherapeutics Inc.: Q4 Earnings Snapshot - theheraldreview.com

Mar 13, 2026

Mar 12, 2026

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update - Bitget

Mar 12, 2026

Bolt Biotherapeutics 2025 Financials: Loss Narrows to $33.4MNews and Statistics - IndexBox

Mar 12, 2026